Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome-Reference-Cited by-同舟云学术

Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome

Published:2017-05-23 Issue:6 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

D'Angelo Arianna¹,Amso Nazar N²,Hassan Rudaina³

Affiliation:

1. Cardiff University School of Medicine; Obstetrics and Gynaecology; Cardiff Wales UK

2. Cardiff University School of Medicine; Emeritus Professor; Cardiff Wales UK CF14 4XN

3. Cardiff University; Wales Deanery; Heath Park Cardiff UK CF14 4YS

Publisher

Wiley

Subject

Pharmacology (medical)

Reference40 articles.

1. A prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS;Aboulghar;Reproductive Biomedicine Online,2007

2. Comparison of coasting with aspiration half of follicles before hCG injection for prevention of OHSS in ART cycles;Aflatoonian;Human Reproduction,2006

3. Dalal R Mishra A Comparison of coasting with cabergoline administration for prevention of early severe OHSS in ART cycles BJOG Eposter 2014 78

4. Early unilateral follicular aspiration compared with coasting for the prevention of severe ovarian hyperstimulation syndrome: a prospective randomized study;Egbase;Human Reproduction,1999

5. Follicle stimulating hormone (FSH) administer with trigger dose human chorionic gonadotropin (hCG) completely prevents ovarian hyperstimulation syndrome (OHSS). Randomised controlled trial;Egbase;Fertility and Sterility,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calcium versus cabergoline for prevention of ovarian hyperstimulation syndrome: A systematic review and meta-analysis;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-10

2. Risk factors, management, and future fertility of empty follicle syndrome: a retrospective study with real-world data;Frontiers in Endocrinology;2024-07-11

3. Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline;Fertility and Sterility;2024-02

4. Follitropin delta combined with menotropin in patients at risk for poor ovarian response during in vitro fertilization cycles: a prospective controlled clinical study;Reproductive Biology and Endocrinology;2024-01-02

5. The HERA (Hyper-response Risk Assessment) Delphi consensus for the management of hyper-responders in in vitro fertilization;Journal of Assisted Reproduction and Genetics;2023-09-15